Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
E•••• V•••••• M•••••••••
E•••• V•••••• M••••••••• builds companies that apply transformative life science technologies to solve problems in healthcare and beyond. The E•••• investment portfolio is balanced across healthcare IT and services, diagnostics, medical devices, and life science platforms.
venture manager, reported GAV $107M across 2 vehicles
- Headquarters
- Boston, MAadviserinfo.sec.gov
- Office address
- 71 COMMERCIAL STREET, #248, Boston, MA, 02109adviserinfo.sec.gov
- Business phone
- 781-254-3372adviserinfo.sec.gov
- Website
- e••••••.com
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Mar 6, 2026
- Private funds reported
- 1 (1 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $124Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- business phone
- 781-254-3372adviserinfo.sec.govpublished by the subject
- Sectors
- healthcare, medtech
- Stages
- not stated or not yet read
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| E•••• V•••••• F••• I•• L••• | Fund | unknown | Unknown | $98.8M Mar 26, 2024 | 36 | $0 of $150M | Dec 27, 2011 |
| E•••• M•••••• F•••• L••• | Fund | unknown | Unknown | $8.1M Mar 26, 2024 | 25 | unknown | unknown |
2 departed (kept with end dates)
- E••••• P••••••• · Managing Director · Feb 1, 2008 to Mar 25, 2015 Inference
- S••••• G•••••• · Managing Director · Feb 1, 2008 to Mar 4, 2019 Inference
- Mar 4, 2019S••••• G•••••• (Managing Director) no longer on Schedule A of E•••• V•••••• M•••••••••
- Mar 25, 2015E••••• P••••••• (Managing Director) no longer on Schedule A of E•••• V•••••• M•••••••••
- Mar 29, 2012E•••• V•••••• M••••••••• first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 29, 2012E•••• M•••••• F•••• L••• first reported on Form ADV by E•••• V•••••• M••••••••• (Venture Capital Fund), GAV $121,565,954Fund first reported on Form ADVFundsFactE•••• M•••••• F•••• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 29, 2012E•••• V•••••• F••• I•• L••• first reported on Form ADV by E•••• V•••••• M••••••••• (Venture Capital Fund), GAV $51,211,804Fund first reported on Form ADVFundsFactE•••• V•••••• F••• I•• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Sep 12, 2026Institutional venture firm (confirmed, 95%, cls-1)venture manager, reported GAV $107M across 2 vehicles